EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Current Features

Advertisement

Current features

Navigating Complexity in Master Protocols with Key Operational Partners

Master Protocols have the capacity for great advantages and efficiencies in drug development over traditional trial protocols but can be challenging for sponsors due...
Continue Reading →
Current features

Measuring What Matters: Designing a Future-Fit FSP Model for Modern Drug Development

The Functional Service Provider model has grown from a tactical staffing mechanism into a strategic outsourcing framework that underpins modern clinical development....
Continue Reading →
Current features

Mental Health Applications of Generative Artificial Intelligence

One of the newer areas in which the US Food and Drug Administration (FDA) is exploring its regulatory role is the use of artificial intelligence (AI) in digital ment...
Continue Reading →
Current features

How Global Contact Centre Support Enhances Clinical Trial Success

Redefining Participant Support Through Global Contact Centres As clinical trials continue to expand across geographies and adopt decentralised and hybrid models, ens...
Continue Reading →
Current features

The Silent Document Revolution Unblocking Clinical Trials

For all the innovation reshaping clinical research, one part of the process has remained stubbornly analog: the documents. Protocols, Statistical Analysis Plans (SAP...
Continue Reading →
Current features

Beyond the IDMC: The Value of Safety Review Committees

Continuous monitoring of safety and efficacy data in clinical trials is a fundamental component of modern clinical research. Because monitoring is complex and involv...
Continue Reading →
Quotient

Company Profiles